A review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizures

Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study

(2014) Steve S. Chung et al.   EPILEPSIA

USL255 extended-release topiramate: Dose-proportional pharmacokinetics and tolerability in healthy volunteers

(2014) Annie M. Clark et al.   EPILEPSIA

Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation

(2013) Meir Bialer et al.   EPILEPSIA

Extended-release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate-release formulations

(2012) Ilo E. Leppik et al.   EPILEPSIA

Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate

(2011) Lawrence J. Lambrecht et al.   EPILEPSIA

Spotlight on Topiramate in Epilepsy1

(2008) Katherine A Lyseng-Williamson et al.   CNS DRUGS

Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population

(2007) Keith L. Davis et al.   EPILEPSIA